Therefore, we conclude that the increased tumor growth observed following targeting of Ptch2 is likely unrelated to ligand perception and that the tumor suppressive action of Ptch2 very likely depends on its baseline inhibitory activity towards Smo, which for an as yet unknown reason only becomes apparent in vivo. This evidence concerns the gene PTCH2 and neoplasm.